FDA Clears At-Home Cervical Cancer Screening Tool
The clearance of the Onclarity HPV Self-Collection Kit and approval of the BD Onclarity HPV Assay aim to reduce barriers for unscreened populations.
Latest Articles
Editor's Top Picks
Ordering Both ESR and CRP Tests Could Save Hospitals Nearly $10 Million Per Year, Study Finds
A peer-reviewed economic analysis challenges the assumption that erythrocyte sedimentation rate and C-reactive protein tests are interchangeable, finding that combined testing reduces misdiagnoses and lowers overall costs.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
IMDX Submits Kitted Transplant Rejection Test for FDA Review
The assay is designed to allow transplant centers to perform molecular monitoring for organ rejection in-house rather than using send-out laboratories.
Equipment & Supply Spotlight
Abbott, Flatiron Health Integrate Precision Oncology Tests Into Oncology EMR Platform
The integration gives more than 4,700 oncology providers across 1,600-plus community cancer care centers direct access to order and receive results from multiple precision oncology tests within a single clinical workflow.
News, Know-How & Standards
Disease Detection & Understanding
EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study
The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.
